NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors
Quarterly report [Sections 13 or 15(d)]
Current report
Definitive proxy statements
View and filter by group or type
